According to Malaysian media kosmo's report on May 23rd, while most people are aware of the health risks of smoking, there are still individuals who are unable to quit due to nicotine addiction. Professor Madya Dr. Rusdi Abd. Rashid from the Malaysia University Addiction Science Research Center pointed out that nicotine is not only found in traditional cigarettes but also in e-cigarettes. Additionally, while the number of traditional cigarette smokers is decreasing, the use of e-cigarettes is on the rise. He also mentioned that some people who have never smoked before have developed a smoking habit due to the influence of e-cigarettes.
The number of e-cigarette users is on the rise. However, many smokers actually want to quit but have not been successful. Dr. Lucidi explains that once people become addicted to nicotine, it is difficult to quit smoking. Therefore, they need help from medications and counseling.
He said, "If smokers follow the correct process, they may be able to quit smoking completely within a month. From a treatment perspective, we have nicotine replacement therapy available, along with counseling sessions.
Meanwhile, Lumelife Sdn Bhd's latest approach is to utilize NVP, a form of nicotine replacement therapy resembling a vaporizer. In Australia, NVP has been widely used to assist patients with nicotine addiction. Dr. Lucidi explains that NVP is a safe product for individuals looking to quit smoking.
He said, "I understand that this device is made from a concentration of nicotine and it can help us assist those who want to quit smoking. However, before using NVP, patients need to go see a doctor and get a prescription from the doctor, they cannot use it casually.
The product has been registered, but has not yet been launched in order to increase knowledge and training for doctors in advance. Recently, Lumelife has partnered with UMCAS and the Malaysian Islamic Doctors Organization (PERDIM) to enhance medical knowledge and training regarding NVP prescriptions within the MAF framework, equipping healthcare professionals with the knowledge and skills needed to handle complex emergency situations related to nicotine dependence.
He said that Lumelife will leverage its expertise in the field of medical education to focus on nicotine dependency management under the MAF.
He said, "Through this collaboration, we have jointly developed a comprehensive training program specifically for nicotine dependency management. This program will cover various topics, including the physiological and psychological effects of nicotine, cognitive aspects of addiction, identifying and distinguishing diseases related to vaping, and strategies for smoking cessation using TGA-approved NVP.
Health professionals will have the opportunity to deepen their understanding of health issues related to vaping and enhance their clinical skills in addressing this challenge through lectures, workshops, and clinical sessions. Professor Pan Shidi stated that individuals addicted to nicotine need the help of medication and counseling in order to successfully quit smoking. He mentioned that if smokers fairly go through the process of dependence, they may be able to quit smoking within a month. In terms of treatment options, experts are currently using nicotine replacement therapy and conducting one-on-one counseling sessions.
We welcome news tips, article submissions, interview requests, or comments on this piece.
Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn
Notice
1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.
2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.
3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.
4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.
Copyright
This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.
For copyright-related inquiries, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.
We welcome any corrections or feedback. Please contact us at: info@2firsts.com
